Pracinostat T1890
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Pracinostat is a novel HDAC inhibitor with improved in vivo properties compared to other HDAC inhibitors currently in Clinicalal trials, allowing oral dosing. Data demonstrate that Pracinostat is a potent and effective anti-tumor drug with potential as an
CAS nr:
929016-96-6
Purity:
98%
Molecular Weight:
358,48
SMILES:
C(=O)(/C=C/c1cc2nc(n(c2cc1)CCN(CC)CC)CCCC)NO
Formula:
C20H30N4O2
Pathway:
DNA Damage/DNA Repair,Apoptosis,Chromatin/Epigenetic
Target:
HDAC,Apoptosis,HDAC
